- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lactate dehydrogenase to albumin ratio may predict worsening in lower RTI: Study
South Korea: The lactic dehydrogenase to albumin (LDH/ALB) ratio was discovered to be an independent predictive factor for in-hospital mortality in patients with lower respiratory tract infection (LRTI) in a recent study.
This study was conducted by Bong-Kyu Lee and the team with the objective to test the function of the lactate dehydrogenase to albumin ratio as an independent predictive factor for lower respiratory tract infection mortality in the emergency department (ED). The findings of this work were published in the American Journal of Emergency Medicine on 25th November 2021.
Researchers evaluated the electronic medical records of patients admitted to the ED for the treatment of LRTI between January 2018 and December 2020 for this study. In the emergency department, initial vital signs, laboratory data, and patient severity assessments were obtained. The LDH/ALB ratio was compared to other albumin-based ratios (blood urea nitrogen to albumin ratio, C-reactive protein to albumin ratio, and lactate to albumin ratio) and severity scales (pneumonia severity index, modified early warning score, and CURB-65 scores) that are used to predict in-hospital mortality. To find independent risk variables, multivariable logistic regression was used.
The results of this work were stated as follow:
1. The non-survivor group had a greater LDH/ALB ratio than the survivor group (median: 217.6 vs. 126.4).
2. When the area under the receiver operating characteristic curve (AUC) for predicting in-hospital mortality was compared, the LDH/ALB ratio (0.808) had a wider AUC than other albumin-based ratios and severity scales, except the blood urea nitrogen to albumin ratio.
3. The LDH/ALB ratio was found to be an independent predictor of in-hospital mortality in a multivariable logistic regression study.
The LDH/ALB ratio outperformed other albumin-based ratios and severity measures, according to the researchers. They concluded by stating that the LDH/ALB ratio might be employed as an independent predictive indicator for in-hospital mortality in LRTI patients.
Reference:
Lee BK, Ryu S, Oh SK, Ahn HJ, Jeon SY, Jeong WJ, Cho YC, Park JS, You YH, Kang CS. Lactate dehydrogenase to albumin ratio as a prognostic factor in lower respiratory tract infection patients. Am J Emerg Med. 2021 Nov 25;52:54-58. doi:10.1016/j.ajem.2021.11.028. Epub ahead of print. PMID: 34864628.
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751